Showing results (21-30 of 46) with videos related to
Sort By:
Pageof 5
Oncotarget|April 28, 2016
Inflammatory and immune markers associated with physical frailty syndrome: findings from Singapore longitudinal aging studiesYanxia Lu, Crystal Tze Ying Tan, Ma Shwe Zin Nyunt, et al.Frontiers in Immunology|May 8, 2018
Adaptive NKG2C+CD57+ Natural Killer Cell and Tim-3 Expression During Viral InfectionsHassen Kared, Serena Martelli, Shu Wen Tan, et al.Frontiers in Immunology|March 7, 2024
Corrigendum: Experimental validation of immunogenic SARS-CoV-2 T cell epitopes identified by artificial intelligenceLorenzo Federico, Brandon Malone, Simen Tennøe, et al.Frontiers in Immunology|December 4, 2023
Experimental validation of immunogenic SARS-CoV-2 T cell epitopes identified by artificial intelligenceLorenzo Federico, Brandon Malone, Simen Tennøe, et al.Scientific Reports|December 27, 2024
SLAMF7 defines subsets of human effector CD8 T cellsHassen Kared, Crystal Tan, Vipin Narang, et al.Journal of Immunology (Baltimore, Md. : 1950)|December 19, 2009
AIDS progression is associated with the emergence of IL-17-producing cells early after simian immunodeficiency virus infectionLaure Campillo-Gimenez, Marie-Christine Cumont, Michèle Fay, et al.Science (New York, N.Y.)|October 30, 2020
Fetal mast cells mediate postnatal allergic responses dependent on maternal IgERasha Msallam, Jozef Balla, Abhay P S Rathore, et al.Clinical Immunology (Orlando, Fla.)|December 7, 2024
Deficient SARS-CoV-2 hybrid immunity during inflammatory bowel diseaseAmin Alirezaylavasani, Ingrid Marie Egner, Børresdatter Dahl, et al.Ebiomedicine|October 16, 2023
Hybrid and SARS-CoV-2-vaccine immunity in kidney transplant recipientsHassen Kared, Amin Alirezaylavasani, Katrine Persgård Lund, et al.NPJ Vaccines|October 9, 2024
Vaccine responses and hybrid immunity in people living with HIV after SARS-CoV-2 breakthrough infectionsAmin Alirezaylavasani, Linda Gail Skeie, Ingrid Marie Egner, et al.Pageof 5